Protagonist Therapeutics (PTGX) Shares Issued (2015 - 2025)

Protagonist Therapeutics (PTGX) has 6 years of Shares Issued data on file, last reported at $5.3 million in Q4 2025.

• For the quarter ending Q4 2025, Shares Issued fell 31.57% year-over-year to $5.3 million; the trailing twelve-month figure through Dec 2025 stood at $5.3 million (down 31.57% YoY), and the FY2025 full-year result was $5.3 million, down 31.57% from the prior year.
• Shares Issued retreated to $5.3 million in Q4 2025, from $7.8 million in the prior quarter.
• In the past five years, Shares Issued ranged from a high of $8.1 million in Q2 2023 to a low of $114000.0 in Q4 2023.
• A 4-year average of $4.9 million and a median of $4.6 million in 2023 frame the typical range for Shares Issued.
• Across the five-year window, Shares Issued sank 42.21% in 2023 and jumped 6757.15% in 2024, its largest moves.
• Tracing PTGX's Shares Issued over 4 years: stood at $3.8 million in 2022, then tumbled by 96.99% to $114000.0 in 2023, then jumped by 6757.15% to $7.8 million in 2024, then slumped by 31.57% to $5.3 million in 2025.
• Business Quant data shows PTGX's Shares Issued at $5.3 million in Q4 2025, $7.8 million in Q4 2024, and $114000.0 in Q4 2023.